Bryhali

Bryhali (halobetasol propionate) lotion, 0.01% is a high-potency topical corticosteroid indicated for the treatment of plaque psoriasis in adults. It works by reducing skin inflammation, itching, redness, and swelling.

Dosage by Body Weight

Apply a thin layer to the affected areas once daily. Rub in gently. Do not exceed a maximum dose of 50 grams per week. Discontinue treatment when control is achieved. Do not use for longer than 8 weeks.

  1. Body Weight
    Below 5 kg
    Dose
    Not recommended
    Frequency
    Do not use
    Tracking Notes
    Safety and effectiveness in pediatric patients have not been established.
  2. Body Weight
    5-7 kg
    Dose
    Not recommended
    Frequency
    Do not use
    Tracking Notes
    Safety and effectiveness in pediatric patients have not been established.
  3. Body Weight
    8-10 kg
    Dose
    Not recommended
    Frequency
    Do not use
    Tracking Notes
    Safety and effectiveness in pediatric patients have not been established.
  4. Body Weight
    11-15 kg
    Dose
    Not recommended
    Frequency
    Do not use
    Tracking Notes
    Safety and effectiveness in pediatric patients have not been established.
  5. Body Weight
    16-20 kg
    Dose
    Not recommended
    Frequency
    Do not use
    Tracking Notes
    Safety and effectiveness in pediatric patients have not been established.

Formulation

Lotion

Purpose

Topical treatment of plaque psoriasis

Generic Name

Halobetasol propionate

Scheduled Drug

No. This medicine is generally not treated as a scheduled/prescription-only drug in common consumer references, but local rules may vary.

Alternatives

LexetteUltravateClobexDuobrii

Disclaimer: This information is for educational purposes only. WHO references and weight bands are simplified for tracking and must not replace medical advice. Always consult with a healthcare professional before starting or changing any medication.